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Abstract: 
During the past decade, the number of studies describing nanostructured lipid carriers (NLC)-based formulations has 
been dramatically increased. The raise in NLC exploitation is essentially due to defeated barriers within the 
technological process of lipid-based nanoparticles’ formulation and increased knowledge of the underlying 
mechanisms of transport of NLC via different routes of administration. This review article aims to give an overview 
on the current state of the art of nanostructured lipid carriers as controlled drug delivery systems for future clinics 
through novel NLC applications providing examples of successfull outcomes. The reported data clearly illustrate the 
promise of these nanoparticles for novel treatments in the near future.  Nanostructured lipid carrier (NLC), have been 
studied for their capability as biodegradable, biocompatible, and physiological lipids are generally used to prepare 
these nanoparticles. Hence, toxicity problems related with the polymeric nanoparticles can be minimized. 
Furthermore, stability of the formulations might increase than other liquid nano-carriers due to the solid matrix of 
these lipid nanoparticles. These nanoparticles can be produced by different formulation techniques. Scaling up of the 
production process from lab scale to industrial scale can be easily achieved. Reasonably high drug encapsulation 
efficiency of the nanoparticles was documented. 
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INTRODUCTION: 
Over the last 20 years, nanotechnology has almost 
made its influence in all technical fields, including 
pharmaceutics. Industry estimations are propose that 
around 40% of lipophilic drug candidates are fail, 
because of their  solubility and stability issues of  
formulations, which has been resolved by various 
advanced and novel lipophilic drug delivery 
technologies. The lipids employed to formulate lipid 
nanoparticle are generally physiological lipids i.e. 
(biocompatible and biodegradable) along with low 
acute and chronic toxicity- 
 
The first generation of SLNs was established in initial 
of 1990. The merits of SLNs there physiological lipids 
are use in SLNs, not use of organic solvents, and the 
ability of large-scale production. As a drug delivery 
system, SLNs can develop bioavailability, creates 
shield on sensitive drugs from a rigorous environment, 
and control drug-release features. However, SLNs 
show some demerits as drug carriers containing a 
random gelation tendency, polymorphic change, and 
low incorporation due to the crystalline structure of 
solid lipids in formulations. At the turn of the era, 
nanostructured lipid carriers (NLCs) are present 
there to resolve, in certain cases, the problems raised 
by SLNs. NLCs are designed by controlling the 
mixing of both solid lipids with liquid lipids, 
projecting to special nanostructures in to the matrix. 
The new generations i.e. NLCs can be avoid the 
apparent drawbacks of SLNs, such as limited drug-
loading capability and drug exclusion during storage 
of formulation, - 
Fang, A Al-Suwayeh et al. (2013)Types of NLCs  
On the basis of using various methods of production 
and the composition of the lipid mixtures, different 
types of NLCs are achieved. The basic idea is to 
deliver a certain NLCs for the lipid matrix which is 
able increase the pay-load for active moiety and 
reduce the expulsion of compound during the time of 
storage. 
 
 There are three types of NLCs:-  
 1. The imperfect type,   
2. The amorphous type, and 
 3. The multiple types.  
The SLNs have limited drug loading capacity because 
of the formation of the lipid crystal. Towards a perfect 
concentration drug expulsion has been observed due to 
an ongoing crystallization development; therefore by 
avoiding crystallization, one can avoid these obstacles 
which is realised in the NLC type 2. The lipid matrix 
is solid but not crystalline, rather it is in an amorphous 
state (as shown in Table I). This can be achieved by 
mixing special lipids, for example, 
hydroxyoctacosanyl hydroxystearate with iso-
propylmyristate. Th e form of fi ne droplets 
incorporated into the third type of NLC is a multiple 
system; comparable to w/o/w emulsions, that is oil-in-
solid lipid-in-water dispersion. The solid lipid matrix 
contains tiny liquid oil nano-compartment particles. 
This type of NLC uses the fact that for a vast category 
of drugs, the solubility in oils is higher than their 
solubility in solid lipids (Uner and Yener 2007). 
 
Fig No. 1 Schematic diagram illustrating structures of NLCs (1, 2, and 3 are disorder structure, amorphous 
structure and multiple structure, respectively) 
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Formulation Ingredients 
 
Examples 
Solid lipids Stearic acid, Glyceryl Monostearate (GMS), Carnauba 
wax [138] Cetyl palmitate, Glyceryl Palmitostearate 
(Precirol® ATO 5), Glyceryl Behenate (Compritol® 
888 ATO), Grades of Witepsol®, Grades of 
Softisan®,Gelucire® 
Liquid lipid Soybean oil, Medium chain triglycerides 
(MCT)/caprylic and capric triglycerides, Oleic Acid 
(OA), Isopropyl Myristate, α-tocopherol/ Vitamin E, 
Corn oil, Squalene 
Surfactants Poloxamer 188, Tween® 20, Tween® 80, Sodium 
dodecyl sulfate (SDS), Sodium deoxy cholate (SDC) 
Myverol™ 18-04K, Polyvinyl alcohol (PVA), Solutol® 
HS 15, Polyoxyl castor oil, Lecithin. 
Table 1 Formulation ingredients for NLC. 
PREPARATION METHODS FOR NLCs:- 
A. High Pressure Homogenization Technique-  
The HPH technique is well known for its large scale 
production of lipid NLCs as well as for good yield. In 
this process liquid forcing under high pressure of 
about 100-200 bars through a narrow orifice. The high 
pressure is creates shear stress due to this cavity made 
to break-down particles into nano-size range. HPH 
method is categorized into two types as follow: - hot 
homogenization and cold homogenization. In both the 
techniques, the lipids are kept at approximately 5-10º 
C above to melting point and then drug is added to the 
melted lipid.   
 
B. Hot Homogenization Technique  
Here the drug-molten lipid solution is homogenously 
dispersed in the aqueous surfactant solution which is 
also having the same temperature as like the drug-lipid 
solution. The assembly is interfuse to produce a high 
shear device to permit continuous stirring. The 
obtained pre-emulsion is forced to words the piston of 
homogenizer for making uniform particles and then 
nanoemulsion can recrystallize by cooling by 
lyophilization forming nanostructured lipid carrier. 
 
C. Cold homogenization technique  
 The hot homogenization technique have certain 
complications with respect to partitioning of the API 
into aqueous surfactant phase leading to drug loss & 
drug degradation at high temperature. These problems 
are avoided by using of cold homogenization 
technique. The first step in this process is similar to hot 
homogenization, followed by rapid cooling of mixture 
solution which distributes the active moiety uniformly 
in the lipid matrix. This technique is suitable for 
thermos-labile drugs.- 
 
D. Solvent Diffusion  
Organic solvents are saturated in water to confirm the 
early thermodynamic equilibrium. The transitory 
oil/water emulsion is passed in to water under the 
constant stirring, which further goes in to 
solidification of dispersed phase forming NLCs 
because diffusion of the organic solvent. For 
dissolving a lipid aqueous immiscible solvents are 
used. Lyophilisation or ultra-filtration is required. 
Organic solvents filtrate may remain in the 
preparation. 
 
E. Solvent emulsification-evaporation 
In aqueous-immiscible organic solvent lipid are 
dissolve, and then emulsified in an aqueous phase 
having surfactants under constant stirring. The organic 
solvent will evaporate in the course of emulsification, 
causing the lipid precipitation. This method is suitable 
for thermolabile drugs. In this very dilute NP’s are 
created. But organic solvent may possibly remain in 
the preparation. So the ultrafiltration or evaporation 
process is required. 
 
F. Melting dispersion method 
In melting technique, solid lipid and API are melted in 
an organic solvent held as oil phase, and concurrently 
water phase is also heated to the similar temperature 
as oil phase is having. Afterward, the lipid phase is 
added to a small amount of aqueous phase and the 
obtained emulsion is goes under the high speed stirring 
for few hours. To end with, product is cooled down to 
room temperature to obtain good yield NLCs.   
 
 G. High shear homogenisation and/or 
ultrasonication technique 
This method is very less frequently used for the 
production of lipid nanoparticles. Initialy, the essential 
drug material is melted by the addition of 
phospholipids along with an aqueous phase, and lastly 
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diffusing the melted material at high temperature by 
automated stirring or ultrasonication technique. 
 
H. Solvent injection (or solvent displacement) 
technique  
Liquid is dissolved in a solvent like ethanol or DMSO, 
which help to diffuse very quickly in water. Then 
mixture is injected into an aqueous-surfactant solution. 
The solvent, because of diffusion in water, migrates 
rapidly in to the aqueous phase; lipid particles in the 
precipitate are leaved. Although this technique serves 
low shear, disadvantage is usage of organic solvents 
and it is remains in product.   
 
I. Double emulsion technique  
This technique is appropriate for encapsulating the 
hydrophilic drugs and usages w/o/w double emulsion 
technique. In double emulsion the drug and surfactant 
are encapsulated in the inner phase. Favorable 
stabilizer is dispersed in the aqueous phase having 
hydrophilic emulsifier which is help for stabilizing the 
primary emulsion. 
 
J. Phase inversion 
In this lipid, drug, water and surfactant are mixed well 
together and give magnetic stirring to solution, three 
heating and cooling cycles are performed, and then 
diluted by using cold water it causing phase inversion 
of the prepared emulsion and breaking resulting in 
formation of NLC. The advantages of this method is 
Thermolabile drugs can be incorporated in procedure. 
Avoidance of organic solvent can be possible. But it is 
unwieldy used technique. 
 
CHARECTERIZATION: 
Characterization techniques: 
Characterization of NLC is a critical requirement 
similar to all other colloidal carriers system for 
evaluating quality, stability, efficacy and release 
kinetics of the delivery system. For SLN and NLC, it 
is pretty a challenging job as a being of an extremely 
small size. These characterization techniques are the 
measurement of morphology of the particles, particle 
size and its distribution, structural properties, surface 
charge and changes in crystallinity of particles, 
polymorphism and thermal behavior of the lipids, 
significant characterization methods for NLCs are 
given below: 
 
I. Particle size and distribution 
Particle size and its distribution is a most important 
characteristic which is shows effect on the solubility, 
stability, release rate pattern and biological action of 
the NLC. The diameter of NLC is ranging from 10 to 
1000nm. Nevertheless, for site-specific delivery of 
drug, a 50–300nm range is desired particularly for 
CNS disorders and chemotherapeutics. This size range 
offers an easier crossing of barriers, increased uptake 
in cells and rapid action while, the size above 300nm   
make available to give sustained drug delivery. Sizes 
which are above than 300nm are desirable for 
intestinal delivery. Increase in particle size during 
storage shows agglomeration and therefore physical 
instability observed. A number of factors including 
composition of the formulation, the manufacturing 
process such as choice of process, equipment used, 
processing temperature, pressure and number of 
successions during HPH technique, sterilization, 
lyophilization these all are affect particle size. In 
general, a high surfactant/lipid ratio results in smaller 
particles size and particle size increase is with low 
surfactant concentrations. Higher drug concentrations 
give larger particle sizes in compare to low 
concentrations of drug. The methods like dynamic 
light scattering (DLS), quasi-light scattering (QLS), 
Photon correlation spectroscopy (PCS), multi-angle 
light scattering (MALS), quasi-elastic light scattering 
(QELS), are generally used, which are give 
information about size based on the corresponding 
hydrodynamic diameter in liquid dispersions.  
 
II. Polydispersity Index 
As we know SLNs/NLCs are generally having 
polydisperse nature, so the measurement of 
polydispersity index (PI) is very important to ensure 
the size distribution of the nanoparticle system. There 
must be lower PI value is required for more 
monodispered nanoparticle dispersion. Most of the 
researchers admit PI value less than 0.3 as optimum 
value. PI can be measured by using the PCS technique. 
 
III. Zeta Potential 
The zeta potential (ZP) specifies the overall charge a 
particle gets in a specific medium. The ZP is shows the 
amount of repulsion among the close and similarly 
charged particles in the prepared dispersion. High ZP 
shows highly charged particles medium. The stability 
during storage can be predicted form the ZP value. 
Generally, higher the ZP (negative or positive) can be 
prevent accumulation of the particles caused by 
electric repulsion and it was electrically stabilizes the 
dispersion. But, if in case of low ZP, attraction goes 
above to the repulsion and the dispersion coagulate so 
flocculation prodused. However, this assumption is 
not valid for all colloidal dispersion; particularly the 
dispersion which is contains tericstabilizers. The ZP 
value of −30 mV is adequate for good stabilization. 
The Zeta Potential can be determined with the help of 
PCS technique. 
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IV. Crystallinity and lipid modification 
To achieve the stable NLCs the characterization of 
crystallinity and the degree of lipid modification is 
necessary. Further, these can be influence the 
entrapment efficiency (EE) and release kinetics. 
Generally used techniques such as “Differential 
scanning calorimetry” (DSC) and “X-ray diffraction” 
(XRD) for determining the structural characterization 
of particles and provide valuable data with respect to 
crystallinity and polymorphism of sample. DSC is 
very sensitive instrument that’s way it is helps to 
understand the structural properties of a sample by 
determining heat exchanges i.e. under controlled 
temperature conditions the uptake or emission of 
thermal energy is carried out during period of melting 
or crystallization of sample. In DSC, firstly sample is 
heated and then cool down at a controlled rate and the 
flow of heat either uptake or emission is quantitatively 
checked. Although DSC instruments of high sensitive 
it can measure the minutest thermal changes, but it 
does not provide any information about the cause of 
these thermal events. The reason of these thermal 
changes such as melting, polymorphic 
transformations, dehydration, decomposition or 
degradation of the sample, these all can determined by 
using other complementary methods such as 
microscopy, XRD, thermo gravimetry or other 
spectroscopic techniques and these are helping to 
overcome the above problems.  
 
V. Electron Microscopy   
With the help of scanning electron microscopy (SEM) 
and transmission electron microscopy (TEM) the 
particulate radius and size distribution of NLCs can be 
measured, in case of observing the shape and 
morphology of the particles the electron microscopy is 
useful. TEM method consumes electrons transmitted 
through the specimen and SEM employs electrons 
transmitted from the surface of the sample. SEM holds 
high resolution and easy preparation of the samples. 
And after freeze-drying or freeze-thawing TEM 
permits visualization of nanoparticles.  
 
VI. Atomic Force Microscopy (AFM)   
For measuring the morphological and surface 
structures of extremely small particles the AFM is 
supreme technique. It doesn’t uses photons or 
electrons but there is a very small sharp-tipped probe 
is situated at the free end of a beam which is passes by 
attractive forces among the tip and specimen surface. 
Even though electron microscopy is still repeatedly 
used, the AFM method offers considerable benefits: 
flexibility in ambient working situations, actual 
quantitative data gaining in three dimensions, nominal 
sample preparation times, and effective 
magnifications at the nano levels.  
 
VII. Surface Tension  
 The surface tension of water at 20°C is about 72.8 
dynes/cm. The addition of emulsifiers and lipid can 
knowingly decrease the surface tension to a lower 
value. The surface tension is decreases subsequently 
with increase of emulsifier concentration. Surface 
tension of the nanoparticles system is regularly 
measured by the Wilhemy plate method. 
 
VIII. Nuclear Magnetic Resonance (NMR)   
To examine the mobility of the sample materials in the 
inner core of NLC, proton NMR spectroscopy is done. 
Movement of the solid lipids and liquid lipids is linked 
with width at half amplitude of the signals. Wide-
ranging signals and small amplitudes are features of 
molecules to the limited movement and strong 
interactions between molecules. The greater contour 
width of NLCs linked to the physical mixture of the 
materials added in NLCs leads to interaction of liquid 
lipid with solid lipid. Immobilization of the NLC 
particles is the stronger in compare to SLNs with 
totally crystallized cores.  
 
IX. Raman Spectroscopy  
Raman spectroscopy based on inelastic scattering of 
monochromatic light, it is detects vibrations and 
rotation of molecules afterward excitation due to 
strong laser beam. Expressing wavenumber in RS is 
inverse centimeter (cm-1). The water causes only 
broad peaks at 3500 cm-1. With respect to the aspect 
of oil incorporation in to crystalline lattice, the bands 
signifying order of lipid chains are to be concern. 
 
X. Determination entrapment efficiency 
The drug-loaded sample was ultracentrifuge at 12,500 
rpm about 45min to separate the aqueous phase and 
lipid phase. The supernatant phase was then diluted by 
methanol, then it filtered through 40lm filter paper and 
the drug content was determined by UV-Visible 
spectrophotometer at 396nm.  
The EE% of NLCs was determined by using the 
equation as follow: 
Entrapment efficiency % = (
Wa−Ws
W𝑎
) × 100 
                                        
Where, Wa means mass of drug added in to the NLCs 
formulation and Ws means analyzed weight of the 
drug in supernatant liquid. 
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XI. Drug release kinetics  
The in vitro drug release model show highest value of 
the R2 was measured as best model for release from 
NLC design. The controlled or sustained release 
manner of drugs from NLCs formulation can be end 
result is prolonged half-life of formulation and 
retarded enzymatic action in systematic circulation. 
The drug release manners from NLCs are reliant on 
the production temperature, on emulsifier 
composition, and oil % incorporated in the lipid 
matrix. The dialysis technique and the use of Franz cell 
are the methods for determining in vitro drug release 
by NLCs. The interpretation of in vitro drug release 
profiles should consider the specific environment in 
the in vivo status. And the enzymatic degradation of 
lipoidal nanostructures may be influenced to a relevant 
amount by their composition of the particles. 
Mathematical models of drug release as follow:  Zero 
order, First order, Higuchi, Hixson-Crowell,  Ritger-
Peppas-Kormeyers, Brazel-Peppas, Hoffenberg, 
Baker-Lonsdale Weibull and Peppas-Sahlin. 
XII. Stability study 
The optimized NLC dispersion was subjected to 
stability study to assess evaluation of any physical or 
chemical changes during storage. For stability study 
the formulation was held in reserve at refrigerated 
condition (4±2° C) and at 25±2C/60±5% RH for 60 
days in Borosil amber-colored glass container. The 
sample testing was done at intervals of 15, 30, 45 and 
60 days after storage. Test samples from each formula 
at each temperature were analyzed for drug retaining 
efficiency. Also the NLC dispersion is visually 
examined for checking any physical instability 
(separation, aggregations, and so forth). 
 
DRUG DELLIVERY BY NLCs- 
NLCs as drug carriers for oral administration 
The oral drug administration route is regarded as most 
common,  because it offers a valuable option for 
treating numerous deadly diseases for the reason that 
of its having several advantages like patient 
compliance, cost–effectiveness and ease of 
administration. It is also highly chosen for chronically 
administered agents, such as antidiabetic, anti-tumor 
and antihypertensive agents.  Charman and his 
colleagues are performed serious studies about the 
correlation between absorption enhancement and 
types of lipid used in formulation. A number of drugs 
were used in NLCs preparation for oral delivery. In 
most of the cases, aim was to increase oral 
bioavailability by means of increasing GI absorption 
or by bypassing the first-pass metabolism of the drug. 
Oral drug delivery systems occupy major share of the 
drug delivery in market, but oral drug delivery is 
constantly interested in newer option due to clumsy 
factors like low drug solubility, poor absorption 
window, rapid metabolism, high variability in the drug 
plasma level, and variability due to food effects. These 
factors may cause unacceptable in vivo results leading 
to failure of the oral delivery systems. From the past 
few years’ colloidal drug carriers, such as, micelles, 
liposomes, neosomes, nanoemulsions, 
nanosuspensions and polymeric nanoparticles have 
overcome numerous above mentioned problems. But, 
these systems are also allied with several downsides as 
such as limited physical stability, accumulation, low 
yield, drug leakage on storing, presence of organic 
solvent residues, cytotoxicity, etc. Lipophilic 
compounds are being manufactured in lipid NPs for 
drugs to be given by oral route. Used for in vivo 
concert of poorly water soluble drugs are given orally, 
the limiting aspect is their resistance to being wetted 
and dissolution into the fluid in the GIT taking into 
consideration of potential degradation in the GIT and 
hence the rise in the dissolution rate of lipophilic drugs 
is related for optimizing BA. Lipid NLCs for oral route 
are related with their adhesive properties, as, once they 
are adhered to the GIT wall, they will be able to release 
the drug exactly wherever it should be absorbed. 
 
Topical delivery: 
Topical delivery is the desired way for skin diseases 
because of reduced systemic side effects as compared 
to oral and parenteral routes. It also avoids the first 
pass effect and keep maintain the concentration of 
drug at the site of action for longer duration 
particularly for drugs which have faster elimination. 
The major challenge is the low uptake of the drug 
because of the stratum corneum layer, which acts as an 
obstacle to toxic molecules along with therapeutics. In 
the recent years, lipid nanoparticles have extended 
consideration as novel colloidal carrier system for 
topical use. NLCs possess many benefits over 
conventional creams and emulsions by provides the 
controlled release action, protection of active moiety, 
improved permeability into the skin and minimum 
skin irritation. Greater drug release was observed with 
NLC. Examples - anti-inflammatory drugs such as 
flurbiprofen, indomethacin, celecoxib, various NLC 
formulations for topical delivery. eg-Lutein was also 
loaded in NLCs produced by highpressure 
homogenization to protect skin from photodamage. 
Eg:- If NLCs showed diameter range 150–350 nm, a 
zeta potential range - 40 to - 63 mV, and the 
encapsulated lutein remained in the skin, protecting 
the skin against UV.The important parameters for 
multiple-type topical formulations are their 
emolliency, which is affected by lubricity and 
spreading properties. Lubricity and spreadibility are 
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related to the formulation’s ability to cover a surface 
and reduce the attrition, and these properties can be 
determined quantitatively. Although being 
independent on the properties of the applied surface, 
lubricity is expressed as a friction factor described by 
Stocke’s law of friction:   F6r ph n=   where   h   stands 
for viscosity,  r  is the film thickness and  v  is the speed 
of moving film. In contrast, spreadibility is highly 
dependent on the applied surface, being described by 
the contact angle :   S R r =/   where  R  is the radius 
of the wetted area and  r is the radius of the initial 
droplet. Young’s law describes the force balance at 
interfaces between solid substrate, liquid and gas 
phase. 
 
NLCs for parenteral administration  
The parenterals of lipidic substances came to success 
while submicron emulsion based products, for 
example Diazemuls and Diprivan were 
commercialized in the marketplace of pharmaceutical 
industry. Liposomes are signifying the 1st generation 
of the novel lipidic carrier system, which is 
modernized the scenario in parenteral drug delivery 
system. But they having the certain disadvantages like 
instability, high cost etc. Then potentials of SLN and 
NLC have been discovered in the parenteral drug 
delivery. The administration of SLN or NLC via the 
parenteral route improved bioavailability (BA), 
targeting and improved cytotoxicity beside multidrug 
resistant cancer cells have been observed.  In study 
done by Jia and colleagues established silybin loaded 
NLC to see the outcome of bio distribution and 
pharmacokinetics afterward to the parenteral 
administration. Silybin loaded NLC exhibited greater 
AUC values and circulated in blood stream for an 
extended time in compare to the silybin solution. The 
tissue distribution is confirmed a high uptake value of 
silybin-NLC in RES organs mainly in liver. 
 
Therapeutic challenges 
The LNPs have been offered for delivery of several 
drugs and activities for numerous purposes. The 
analysis of all the uses of LNPs overcomes the purpose 
of this review. However, amongst the most fascinating 
and recent everyday jobs for LNPs, there are several 
challenges that are becoming the hot topic of drug 
therapy these days. Anticancer therapy, the 
overcoming of the blood--brain barrier (BBB), protein 
and gene delivery are research fields where the 
necessity of a safe and versatile drug carrier is vital, 
and LNPs have been proposed and verified to these 
goals. 
 
Cancer therapy 
 The underlying principle of using Lipidic 
Nanoparticles for anticancer therapy is based on 
several physiological mechanisms. A tumor is often 
related with a defective, leaky vascularization as an 
outcome of the poorly regulated nature of tumor 
angiogenesis. To rise in cancer cell-selective 
cytotoxicity, a methodology that is gaining attention to 
surface-engineer NPs for active targeting is done. This 
strategy heroically acts the differences among cancer 
cells and healthy cells, in specific surface antigen (Ag) 
differences. Few primary examples are present in 
LNPs: in particular targeting through folate, 
transferrin and lectin receptors have been projected. 
Nanotechnology-based drug delivery systems are 
leading to cancer therapeutic modalities that are not 
only less toxic to the patient but also significantly more 
efficacious, carrying a significant promise toward new 
ways of treating cancer. 
 
Carriers for Antitumor Drugs  
The PNP drug delivery system is a highly valuable 
application for antitumor therapy. PNPs can regulate 
the drug release, prolong drug retention time in the 
body, and increase drug targeting at tumor site (and so 
efficacy) while reducing adverse side effects of drug. 
Also, the enlarged permeability of PNP improves the 
penetration of the drug in tumor cells. The mechanism 
of PNP transport across the cell membrane is differs 
from the free drug. PNPs are incorporated through 
endocytosis and therefore their uptake is not affected 
by the drug transporters in the cell membrane. Thus a 
combination of PNPs and antitumor drugs can avoid 
the multi-drug resistance of tumor cells facilitated by 
drug transporters.  a tumor is often allied with a 
defective, leaky vascular construction as a outcome of 
the badly regulated environment of tumor 
angiogenesis. In interstitial fluid inside a tumor is 
usually inadequately drained by the badly formed 
lymphatic system. Hence, outcome submicron sized 
particulate issue may specially extravasate into the 
tumor and be retained there. This is said as the 
“enhanced permeability and keeping” (EPR) effect. 
This EPR effect can be taken benefit of by a properly 
considered nanoparticle scheme such as NLC to attain 
passive tumor targeting. By doing so, the above-
mentioned poor tissue specificity difficulty can be 
around partly solved. 
 
GENE DELIVERY  
 For the treatment of human diseases the development 
of gene therapy has boosted the usage of new crowds 
of gene delivery system. Nonviral vectors are widely 
investigated because of their adequate safety. Lipid 
nanocarriers, including liposomes and SLNs, can 
increase the Gene Delivery PLNs are used to delivery 
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genes that can be conveyed by non-viral vectors, such 
as cationic liposomes (DOTAP) and cationic polymers 
(PEI). Although liposomes and polymers have been 
shown to be effective both in vitro and in vivo, their 
action is limited by instability after administration. 
Moreover, the cationic surface of some polymers 
easily combines with serum proteins, leading to rapid 
removal from the systemic circulation and non-
specific uptake by non-target tissues. Therefore, 
liposomes and polymers are not optimal gene delivery 
vehicles. Li et al. initiate that PLNs show greater 
stability and good biocompatibility compared with 
liposomes and PNPs. In one preparation of LPNs 
containing DNA, unmodified LPNs were composed of 
a PEI core and a polycarbonate three OA glycerin ester 
two stearic acylphosphatidylcholine lipid shell. 
Modified LPNs were delivered to HEK293 cells and 
MB MDA 231 breast cancer cells. The transfection 
efficiency was higher than when using liposomes; the 
colloid was more stable, and the toxicity to the 
HEK293 and MB MDA 231 breast cancer cells by the 
PLNs was low. 
 
Intranasal delivery 
Intranasal drug delivery is a reliable, safe and 
noninvasive for the delivery of CNS drugs and safe 
alternative to parenteral administration, which offers 
advantages of rapid absorption due to the high surface 
area, rich blood supply and porous endothelium of the 
nasal mucosa, avoiding the gastrointestinal and 
hepatic metabolism, fewer side effects and possibility 
of dose reduction and better patient compliance. NLC 
formulations by the intranasal route have been 
explored thoroughly for enriched delivery to the brain. 
Various pathways have been offered for intranasal 
delivery to the brain via. a) the systemic pathway, 
where the active drug compound is absorbed into the 
blood and by crossing the BBB it goes into to the 
targeted brain tissues; b) the olfactory pathway, where 
the drug is infuses the olfactory epithelium and 
through the olfactory bulb goes into the brain tissue or 
CSF; and c) the trigeminal pathway, where the drug is 
conveyed into the brain via the trigeminal nerve 
system. The olfactory bulb pathway and trigeminal 
nerve system pathways bypass the BBB and have 
gained importance in targeted delivery of a variety of 
therapeutics ranging from small molecules, proteins 
and peptides, stem cells and even plasmids to the 
brain. Several therapeutics such as artemether, 
tarenflurbil , valproic acid, lamotrigine , curcumin , 
proteins have been successfully shown to have 
achieved enhanced brain targeting, indicating 
superiority of intranasal delivery of NLC to the brain 
fig No.2 (Advantages of nanocarrier based pumonary 
drug delivery system) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Advantages of 
nanocarrier 
based pumonary 
drug delivery 
system  
Non-invasive 
nature improves  
patients 
compliance. 
Large surface area 
and abundant 
vascularization in 
lungs allows faster 
drug  absorption .  
Low systemic exposure 
and low enzyme activity 
in lungs protect the 
drug from degradation  
degradation and 
clearance mechanism 
Drug release can 
be tailored to 
the desired the 
rapeutic 
window. 
Enhance the drug 
delivery and thereby 
a therapeutic effects 
in lungs lower 
doses. 
High BA due to 
controlled  absorption, 
restricted BD high 
degree of specificity, 
and retention. 
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Ocular route: 
The eye is a predominantly challenging organ for drug 
delivery systems. The drug bioavailability is limited 
by physical barriers that hinder drug access into the 
eye: (i) muco-aqueous barrier, (ii) corneal epithelium, 
(iii) iris blood vessels lacking on fenestrations, (iv) 
non-pigmented layer of the ciliary epithelium and (v) 
the retinal pigment epithelium (RPE) along with the 
retinal vessels epitheliu. Furthermore, physiological 
processes like blinking and tear drainage reduce the 
residence time of ocular drug delivery systems. 
Depending on the ocular site of administration 
(topical, intravitreal, intravenous, transscleral, 
suprochoroidal or subretinal), differences on the 
clearance and the toxicity of the nanocarrier are 
expected. Among from numerous nanotechnological 
approaches, lipidic nanocarriers have appeared as 
efficient ophthalmic drug delivery systems, 
particulartly NLC, which have been modified to 
prolong drug retention on the corneal surface 
encapsulating different drugs. 
   
 
Table 2 Drug loaded lipid nanoparticles (SLN, NLS) for ocular disorders applications. 
 
CONCLUSIONS: 
NLC is a potential approach for improving the 
bioavailability of highly lipophilic drugs with poor 
aqueous solubility, extensive first pass metabolism, 
affinity for P-gp efflux transporters, and susceptibility 
to intra-enterocyte metabolism. In a way, the high 
caliber of NLC system shadows the petition of other 
lipid-based dosage form. Disrupted matrices of NLC 
consequently lead to higher drug loading, higher drug 
entrapment, modulated drug release and ultimately 
enhanced drug absorption as compared with other 
lipid-based formulations having uniform matrices of 
lipids. These special features of NLC are exclusively 
attributed to their unique composition, which is 
constituted of a blend of incompatible solid and liquid 
lipids. 
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